Table 2 PD-L1 expression in mixed UC/SCC and pure SCC
From: Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
pure SCC | mixed UC/SCC | |||||||
|---|---|---|---|---|---|---|---|---|
Scores | 28–8 | 22C3 | SP 263 | SP142 | 28–8 | 22C3 | SP 263 | SP142 |
TC (%) 0 | 45 | 51 | 33 | 63 | 26 | 39 | 21 | 43 |
TC (%) 1 | 5 | 2 | 10 | 0 | 9 | 2 | 3 | 0 |
TC (%) 2 | 2 | 2 | 4 | 0 | 2 | 1 | 1 | 0 |
TC (%) 3 | 5 | 4 | 5 | 0 | 4 | 1 | 10 | 0 |
TC (%) 4 | 3 | 2 | 6 | 0 | 0 | 0 | 6 | 0 |
TC (%) 5 | 3 | 0 | 5 | 0 | 2 | 1 | 2 | 0 |
IC (%) 0 | 38 | 42 | 24 | 58 | 22 | 35 | 18 | 40 |
IC (%) 1 | 8 | 8 | 21 | 4 | 12 | 2 | 11 | 3 |
IC (%) 2 | 14 | 4 | 14 | 0 | 5 | 6 | 12 | 1 |
IC (%) 3 | 3 | 7 | 4 | 1 | 4 | 1 | 2 | 1 |
CPS < 1 | 18 | 39 | 11 | 49 | 13 | 33 | 8 | 36 |
CPS 1–9 | 32 | 10 | 32 | 13 | 20 | 8 | 15 | 5 |
CPS ≥ 10 | 13 | 12 | 20 | 1 | 10 | 3 | 20 | 1 |